Ausgabe 2/2013
Inhalt (8 Artikel)
Mechanisms and Clinical Efficacy of Lixisenatide for the Management of Type 2 Diabetes
Michael Horowitz, Christopher K. Rayner, Karen L. Jones
Cariprazine in Bipolar Disorder: Clinical Efficacy, Tolerability, and Place in Therapy
Leslie Citrome
Cariprazine in Schizophrenia: Clinical Efficacy, Tolerability, and Place in Therapy
Leslie Citrome
The Impact of 7-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease: A Literature Review
Tin Tin Htar Myint, Harish Madhava, Paul Balmer, Dina Christopoulou, Sepideh Attal, Damianos Menegas, Ralf Sprenger, Eric Bonnet
Effects of Vildagliptin/Metformin Therapy on Patient-Reported Outcomes: Work Productivity, Patient Satisfaction, and Resource Utilization
Stefano Genovese, Donatella Tedeschi
Cost of Cystic Fibrosis: Analysis of Treatment Costs in a Specialized Center in Northern Italy
Carla Colombo, Valeria Daccò, Gianfranco Alicandro, Silvana Loi, Silvio Mazzi, Carlo Lucioni, Roberto Ravasio
Effectiveness and Safety of Aliskiren and Aliskiren Hydrochlorothiazide (HCT) in a Multiethnic, Real-World Setting
Srinivasa Rao Maddury, Abhay Pande, K. M. H. S. Sirajul Haque, Akram Echtay, Loewe Go, Tashbeeb Gulzar, Mahomed Kadwa, Sashka Hristoskova
Effect of Pioglitazone Versus Metformin on Cardiovascular Risk Markers in Type 2 Diabetes
Stefano Genovese, Giorgia De Berardis, Antonio Nicolucci, Edoardo Mannucci, Virgilio Evangelista, Licia Totani, Fabio Pellegrini, Antonio Ceriello